Virus | No. of specimens | Performance of the GeXP assay | ||||||
---|---|---|---|---|---|---|---|---|
GeXP + aRVP + a | GeXP + RVP - | GeXP- RVP + | GeXP-aRVP -a | Sensitivity % | Specificity % | PPVa% | NPVa% | |
FluA | 5 | 0 | 0 | 121 | 100 | 100 | 100 | 100 |
sH1N1b | 3 | 0 | 0 | 123 | 100 | 100 | 100 | 100 |
FluB | 1 | 0 | 0 | 125 | 100 | 100 | 100 | 100 |
PIV1 | 1 | 0 | 0 | 125 | 100 | 100 | 100 | 100 |
PIV2 | 1 | 0 | 0 | 125 | 100 | 100 | 100 | 100 |
PIV3 | 21 | 3d | 0 | 102 | 100 | 97.14 | 87.50 | 100 |
HRVc | 68 | 6 | 3 | 49 | 95.77 | 89.09 | 91.89 | 94.23 |
HMPV | 8 | 0 | 2 | 116 | 80.00 | 100 | 100 | 98.31 |
Adv | 9 | 0 | 1 | 116 | 90.00 | 100 | 100 | 99.15 |
CoV NL63 | 1 | 0 | 0 | 125 | 100 | 100 | 100 | 100 |
CoV OC43 | 12 | 0 | 0 | 114 | 100 | 100 | 100 | 100 |
CoV 229E | 2 | 0 | 0 | 124 | 100 | 100 | 100 | 100 |
CoV HKU1 | 4 | 0 | 0 | 122 | 100 | 100 | 100 | 100 |
RSVAb | 2 | 0 | 0 | 124 | 100 | 100 | 100 | 100 |
RSVBb | 46 | 0 | 3 | 77 | 93.88 | 100 | 100 | 96.25 |
HBoV | 15 | 0 | 4 | 107 | 78.95 | 100 | 100 | 96.40 |